Aarti Drugs Dividende
Zukünftiges Wachstum Kriterienprüfungen 1/6
Aarti Drugs is a dividend paying company with a current yield of 0.21%.
Wichtige Informationen
0.2%
Dividendenausschüttung
1.3%
Rückkaufsrendite
| Gesamte Aktionärsrendite | 1.6% |
| Zukünftige Dividendenrendite | 1.6% |
| Wachstum der Dividende | -29.0% |
| Nächster Dividendenzahlungstermin | n/a |
| Ex-Dividendendatum | n/a |
| Dividende pro Aktie | ₹1.000 |
| Ausschüttungsquote | 0% |
Aktuelle Dividendenentwicklung
Recent updates
We Discuss Why Aarti Drugs Limited's (NSE:AARTIDRUGS) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
Sep 20
Aarti Drugs (NSE:AARTIDRUGS) Has A Somewhat Strained Balance Sheet
Sep 05Is Aarti Drugs (NSE:AARTIDRUGS) A Risky Investment?
May 04Aarti Drugs Limited Recorded A 9.0% Miss On Revenue: Analysts Are Revisiting Their Models
Feb 01Aarti Drugs (NSE:AARTIDRUGS) Is Due To Pay A Dividend Of ₹1.00
Jan 30Aarti Drugs' (NSE:AARTIDRUGS) Anemic Earnings Might Be Worse Than You Think
May 17These 4 Measures Indicate That Aarti Drugs (NSE:AARTIDRUGS) Is Using Debt Reasonably Well
Nov 22We Take A Look At Why Aarti Drugs Limited's (NSE:AARTIDRUGS) CEO Has Earned Their Pay Packet
Aug 28Here's Why We Think Aarti Drugs (NSE:AARTIDRUGS) Is Well Worth Watching
Aug 19Is Aarti Drugs Limited (NSE:AARTIDRUGS) Expensive For A Reason? A Look At Its Intrinsic Value
May 17Here's Why I Think Aarti Drugs (NSE:AARTIDRUGS) Is An Interesting Stock
Apr 04Does Aarti Drugs (NSE:AARTIDRUGS) Have A Healthy Balance Sheet?
Mar 17Aarti Drugs Limited's (NSE:AARTIDRUGS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 02What Percentage Of Aarti Drugs Limited (NSE:AARTIDRUGS) Shares Do Insiders Own?
Feb 17Why Aarti Drugs Limited (NSE:AARTIDRUGS) Should Be In Your Dividend Portfolio
Feb 04
What Can We Learn About Aarti Drugs' (NSE:AARTIDRUGS) CEO Compensation?
Jan 22Aarti Drugs' (NSE:AARTIDRUGS) Wonderful 432% Share Price Increase Shows How Capitalism Can Build Wealth
Jan 07If You Like EPS Growth Then Check Out Aarti Drugs (NSE:AARTIDRUGS) Before It's Too Late
Dec 23Aarti Drugs (NSE:AARTIDRUGS) Seems To Use Debt Quite Sensibly
Dec 08Aarti Drugs Limited's (NSE:AARTIDRUGS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Nov 23How Much Of Aarti Drugs Limited (NSE:AARTIDRUGS) Do Insiders Own?
Nov 08Here's What We Learned About The CEO Pay At Aarti Drugs Limited (NSE:AARTIDRUGS)
Oct 11Stabilität und Wachstum des Zahlungsverkehrs
Rufe Dividendendaten ab
Stabile Dividende: AARTIDRUGS's dividend payments have been volatile in the past 10 years.
Wachsende Dividende: AARTIDRUGS's dividend payments have fallen over the past 10 years.
Dividendenrendite im Vergleich zum Markt
| Aarti Drugs Dividendenrendite im Vergleich zum Markt |
|---|
| Segment | Dividendenrendite |
|---|---|
| Unternehmen (AARTIDRUGS) | 0.2% |
| Untere 25 % des Marktes (IN) | 0.2% |
| Markt Top 25 % (IN) | 1.1% |
| Branchendurchschnitt (Pharmaceuticals) | 0.7% |
| Analystenprognose (AARTIDRUGS) (bis zu 3 Jahre) | 1.6% |
Bemerkenswerte Dividende: AARTIDRUGS's dividend (0.21%) isn’t notable compared to the bottom 25% of dividend payers in the Indian market (0.24%).
Hohe Dividende: AARTIDRUGS's dividend (0.21%) is low compared to the top 25% of dividend payers in the Indian market (1.09%).
Gewinnausschüttung an die Aktionäre
Abdeckung der Erträge: Unable to calculate sustainability of dividends as AARTIDRUGS has not reported any payouts.
Barausschüttung an die Aktionäre
Cashflow-Deckung: With its low cash payout ratio (9%), AARTIDRUGS's dividend payments are thoroughly covered by cash flows.